Adam Koppel's Net Worth

$3.28 Billion

Estimate Recalculated Feb 22, 2024 04:09PM EST

Who is Adam Koppel?

Adam Koppel has an estimated net worth of $3.28 Billion. This is based on reported shares across multiple companies, which include BIOGEN INC., Dicerna Pharmaceuticals Inc, MARINUS PHARMACEUTICALS INC, RAPID MICRO BIOSYSTEMS, INC., Arcutis Biotherapeutics, Inc., Foghorn Therapeutics Inc., BCLS Acquisition Corp., SpringWorks Therapeutics, Inc., Replimune Group, Inc., Cerevel Therapeutics Holdings, Inc., PTC THERAPEUTICS, INC., TREVENA INC, Solid Biosciences Inc., Annexon, Inc., and Aptinyx Inc..

SEC CIK

Adam Koppel's CIK is 0001578965

Past Insider Trading and Trends

2020 was Adam Koppel's most active year for acquiring shares with 22 total transactions. Adam Koppel's most active month to acquire stocks was the month of May. 2021 was Adam Koppel's most active year for disposing of shares, totalling 14 transactions. Adam Koppel's most active month to dispose stocks was the month of November. 2023 saw Adam Koppel paying a total of $124,999,986.12 for 5,522,764 shares, this is the most they've acquired in one year. In 2021 Adam Koppel cashed out on 47,343,056 shares for a total of $291,871,552.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN INC. (BIIB) Snapshot price: $241.53

EVP, Strategy and Bus. Dev.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-18.77%
-555.00
$290.00
-$160,950.00
2.4K
Scheduled
Jun 6
Form 4
+60.01%
1.11K
$289.73
-$154,715.82
2.96K
Jun 2
Form 4
-5.23%
-102.00
$275.00
-$28,050.00
1.85K
Scheduled
Apr 6
Form 4
+12.21%
203
$258.99
-$25,381.02
1.87K
Feb 23
Form 4
0
0
Feb 22
Form 4
+1,176.13%
1.53K
$387.62
-$330,252.24
1.66K
Jun 2
Form 4
0
0
Feb 23
Form 4
0
0
Jun 2
Form 3
0
0
No matching records found

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.08M
$38.25
-$117,946,552.50
0
Dec 28
Form 4
3.33K
3.33K
Jun 3
Form 4
-24.51%
-1.00M
$23.40
-$23,400,000.00
3.08M
Dec 10
Form 4
0
0
Jun 15
Form 4
-26.88%
-1.50M
$24.68
-$37,020,000.00
4.08M
Dec 4
Form 4
-23.87%
-1.75M
$22.03
-$38,552,500.00
5.58M
Nov 19
Form 4
0
0
Jun 20
Form 4
-17.92%
-1.60M
$12.50
-$20,000,000.00
7.33M
May 29
Form 4
0
0
Jun 21
Form 4
8.93M
$7.00
8.93M
Dec 18
Form 4
0
0
Jul 18
Form 4
0
0
Apr 11
Form 3
0
0
No matching records found

MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $9.955

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.24%
-1.27M
$7.88
-$10,024,800.93
3.98M
Dec 15 - Dec 19
Form 3
0
0
No matching records found

RAPID MICRO BIOSYSTEMS, INC. (RPID) Snapshot price: $0.978

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
8.43M
$20.00
8.43M
Jul 19
Form 3
0
0
No matching records found

Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.715

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.98M
$17.00
3.98M
Feb 4
Form 3
0
0
No matching records found